Skip to content

Intraperitoneal Mesh-Implementation After Laparotomy

Intraperitoneal Mesh-Implementation After Laparotomy to Reduce Risk of Incisional Hernia: a Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01003067
Enrollment
267
Registered
2009-10-28
Start date
2008-03-31
Completion date
2020-06-30
Last updated
2019-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia

Brief summary

Aim of the study is to evaluate the risk reduction of intraperitoneal mesh-implementation after laparotomy (Group 1) in a randomized control trial compared with patients with standard abdominal closure (Everett-suture). This is the primary endpoint. Second endpoints are the feasibility of mesh-implementation even after colorectal surgery, find risk factors for wound infection and incisional hernia.

Interventions

DEVICEMesh implementation

Prophylactic intraperitoneal mesh implantation in laparoscopic surgery to prevent incisional hernia.

Sponsors

Kantonsspital Liestal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent * Median Laparotomy

Exclusion criteria

* Bowel perforation * Pregnancy * Palliative surgery * Drug abuse * Age under 18 * Mental disability * Allergy to mesh components

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Incisional Hernia At 2 Years Following Median Laparotomy2 yearsPrimary endpoint was the incidence of incisional hernias at 2 years following midline laparotomy.

Secondary

MeasureTime frameDescription
Feasibility of Mesh-implementation Even After Colorectal Surgery, Find Risk Factors for Wound Infection and Incisional Hernia.5 YearsSecondary endpoints are the feasibility, the safety of the mesh stripe implantation including postoperative pain, and the incidence of incisional hernias at 5 years.

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
No Mesh
The closure technique consisted of a single-layer continuous suture technique with picking up all layers of the abdominal wall apart from subcutaneous fat and skin (peritoneum, posterior rectus sheath, rectus muscle and anterior rectus sheath).
136
Mesh Implementation
Mesh implementation: Prophylactic intraperitoneal mesh implantation in laparoscopic surgery to prevent incisional hernia.
131
Total267

Baseline characteristics

CharacteristicNo MeshMesh ImplementationTotal
Age, Customized65.1 years
STANDARD_DEVIATION 2
64.1 years
STANDARD_DEVIATION 2.3
64.5 years
STANDARD_DEVIATION 2
Region of Enrollment
Switzerland
136 participants131 participants267 participants
Sex: Female, Male
Female
80 Participants71 Participants151 Participants
Sex: Female, Male
Male
56 Participants60 Participants116 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
10 / 1364 / 131
other
Total, other adverse events
0 / 1362 / 131
serious
Total, serious adverse events
0 / 1360 / 131

Outcome results

Primary

Number of Participants With Incisional Hernia At 2 Years Following Median Laparotomy

Primary endpoint was the incidence of incisional hernias at 2 years following midline laparotomy.

Time frame: 2 years

ArmMeasureValue (NUMBER)
No MeshNumber of Participants With Incisional Hernia At 2 Years Following Median Laparotomy40 participants
Mesh ImplementationNumber of Participants With Incisional Hernia At 2 Years Following Median Laparotomy18 participants
Secondary

Feasibility of Mesh-implementation Even After Colorectal Surgery, Find Risk Factors for Wound Infection and Incisional Hernia.

Secondary endpoints are the feasibility, the safety of the mesh stripe implantation including postoperative pain, and the incidence of incisional hernias at 5 years.

Time frame: 5 Years

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026